A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Start Date
11/3/2025
Completion Date
2/1/2027
Summary
This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit. Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-week treatment period, 8-week safety follow-up period.
Eligibility Criteria
Age Range: 18 years to 75 years
Interventions
Brenipatide
Placebo
Conditions
Locations
Woodland Research Northwest
Rogers, Arkansas 72758
United States
Hillcrest Medical Research
DeLand, Florida 32720
United States
TecTum Research
Hollywood, Florida 33024
United States
K2 Medical Research ORLANDO
Maitland, Florida 32751
United States
GTL Medical & Research Group
Miami, Florida 33173
United States
North Georgia Clinical Research
Woodstock, Georgia 30189
United States
Revival Research Institute, LLC
Dearborn, Michigan 48126
United States
Arch Clinical Trials
St Louis, Missouri 63141
United States
Vector Clinical Trials
Las Vegas, Nevada 89128
United States
Rochester Clinical Research, LLC
Rochester, New York 14609
United States
Coastal Carolina Research Center
North Charleston, South Carolina 29405
United States
Circle Clinical Research
Sioux Falls, South Dakota 57104
United States
FutureSearch Trials of Dallas
Dallas, Texas 75251
United States
The University of Texas Health Science Center at Houston
Houston, Texas 77054
United States
Health Research of Hampton Roads, Inc.
Newport News, Virginia 23606
United States
Eastside Research Associates
Redmond, Washington 98052
United States
Beijing Chaoyang Hospital, Capital Medical University
Beijing, 100020
China
Beijing Anding Hospital - Affiliated Capital University of Medical Science
Beijing, 100088
China
Sichuan Provincial People's Hospital
Chengdu, 610072
China
2nd Affiliated Hospital Chongqing Medical University
Chongqing, 400072
China
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Hangzhou, 310016
China
Taizhou Hospital of Zhejiang Province
Linhai, 317000
China
The first affiliated hospital of Ningbo university
Ningbo, 315010
China
The University of Hong Kong-Shenzhen Hospital
Shenzhen, 518053
China
Miyazaki RC Clinic
Shinagawa-ku, 140-0001
Japan
Samoncho Clinic
Shinjuku, 160-0017
Japan
Higashi Shinjuku Clinic
Tokyo, 169-0072
Japan